Penetration of the blood-brain barrier has been a difficult task for drugs; however, evidence of anti-CD19 CAR T-cell trafficking to brain tissues and cancer cell elimination supports the concept that CAR-T cells may effectively target HIV reservoirs in the brain tissues (Grupp et al., 2013; Maude et al., 2014). Here, CD19 is linked to cancer.